SCHEMBL7135658

SCHEMBL7135658

COC1CC(C=C2C(=O)Nc3c(Br)cc(Br)c(C)c32)C(OC)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5364320 0.83 — —
SCHEMBL5369219 0.69 MAPT (0.42) —
SCHEMBL7137960 0.67 HSP90AA1 (0.32) —
SCHEMBL7136260 0.67 — —
SCHEMBL7136631 0.65 LRRK2 (0.43) —
SCHEMBL7130885 0.65 SIRT1 (0.41) —
SCHEMBL7139869 0.65 PTPN1 (0.43) —
SCHEMBL7133880 0.65 LRRK2 (0.48) —
SCHEMBL7138260 0.65 METAP1 (0.55) —
SCHEMBL7137199 0.64 MEN1 (0.58) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 — — US disclosed
Send feedback